Pharma Suits Still Low Despite ITC Surge
Though litigation before the U.S. International Trade Commission is surging, the pharmaceutical sector still accounts for a relatively small portion of the cases on the ITC docket. But that could change...To view the full article, register now.
Already a subscriber? Click here to view full article